BackMoleculin Biotech Overview

Moleculin Biotech Selling, General & Admin

Selling, General & Admin expenses for MBRX.

Quarterly SG&A Expenses

$2.49M
↑ 0.44% YoY

As of Mar 31, 2026

Annual SG&A Expenses (TTM)

$9.04M
↑ 1.95% YoY

Trailing 12 months ending Mar 31, 2026

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin